Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial.
第一作者:
J W,de Fijter
第一单位:
Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands.
作者:
医学主题词
女(雌)性(Female);随访研究(Follow-Up Studies);肾小球滤过率(Glomerular Filtration Rate);移植物排斥(Graft Rejection);移植物存活(Graft Survival);人类(Humans);免疫抑制剂(Immunosuppressive Agents);肾功能衰竭, 慢性(Kidney Failure, Chronic);肾功能试验(Kidney Function Tests);肾移植(Kidney Transplantation);男(雄)性(Male);中年人(Middle Aged);手术后并发症(Postoperative Complications);预后(Prognosis);危险因素(Risk Factors);他罗利姆(Tacrolimus)
DOI
10.1111/ajt.14186
PMID
28027625
发布时间
2023-01-24
- 浏览61
American journal of transplantation
1853-1867页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



